Alendronate versus alfacalcidol in the prevention of glucocorticoid-induced bone loss

被引：1
|
作者：
Hahn, Bevra H. [1 ]
Hahn, Theodore J.
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA
[2] W Los Angeles Vet Adm Hlth Care Ctr, Los Angeles, CA USA
来源：
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2007年 / 3卷 / 01期
关键词：
alendronate; alfacalcidol; glucocorticoids; osteoporosis; prevention;
D O I：
10.1038/ncprheum0370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [1] Alendronate versus alfacalcidol in the prevention of glucocorticoid-induced bone loss
    Bevra H Hahn
    Theodore J Hahn
    Nature Clinical Practice Rheumatology, 2007, 3 : 10 - 11
  • [2] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    de Nijs, Ron N. J.
    Jacobs, Johannes W. G.
    Lems, Willem F.
    Laan, Roland F. J.
    Algra, Ale
    Huisman, Anne-Margriet
    Buskens, Erik
    de laet, Chris E. D.
    Oostveen, Ans C. M.
    Geusens, Piet P. M. M.
    Bruyn, George A. W.
    Dijkmans, Ben A. C.
    Bijlsma, Johannes W. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07): : 675 - 684
  • [3] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    Minisola, Salvatore
    Scillitani, Alfredo
    Romagnoli, Elisabetta
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2156 - 2157
  • [4] Prevention of Glucocorticoid-induced Osteoporosis with Alendronate or Alfacalcidol in Patients with Ophthalmologic Diseases
    Ikeda, T.
    Hamanishi, C.
    Souen, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S218 - S218
  • [5] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis - Reply
    de Nijs, Ron N. J.
    Jacobs, Johannes W. G.
    Bijlsma, Johannes W. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2157 - 2157
  • [6] Prevention of glucocorticoid-induced osteoporosis: A randomized clinical trial with alendronate versus alfacalcidol. The Stop-Study
    de Nijs, R
    Jacobs, J
    Buskens, E
    Huisman, A
    Algra, A
    Laan, R
    de Laet, C
    Lems, W
    Bijlsma, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 94 - 94
  • [7] The stop-study: A randomized placebo controlled trial with alendronate versus alfacalcidol in the prevention of glucocorticoid-induced osteoporosis.
    de Nijs, RNJ
    Jacobs, JWG
    Huisman, MAM
    Buskens, E
    Algra, A
    Lems, WF
    Laan, RFJ
    Geusens, PP
    Bruyn, GAW
    Bijlsma, JWJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S295 - S295
  • [8] Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs
    Akahoshi, S
    Sakai, A
    Arita, S
    Ikeda, S
    Morishita, Y
    Tsutsumi, H
    Ito, M
    Shiraishi, A
    Nakamura, T
    JOURNAL OF BONE AND MINERAL METABOLISM, 2005, 23 (05) : 341 - 350
  • [9] Prevention of glucocorticoid-induced osteoporosis with alendronate or alfacalcidol: Relation between change in bone mineral density, bone markers and calcium homeostasis.
    Jacobs, JWG
    de Nijs, RNJ
    Lems, WF
    Geusens, PP
    Huisman, MAM
    Laan, RFJ
    Bijlsma, JWJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S295 - S295
  • [10] Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol
    Takeda, Seiji
    Kaneoka, Hidetoshi
    Saito, Takao
    MODERN RHEUMATOLOGY, 2008, 18 (03) : 271 - 276
12345